BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36449303)

  • 1. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
    Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
    JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral Tnm T1 And T2 Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: Total Thyroidectomy or Lobectomy?
    Wang Z; Xiang J; Gui Z; Qin Y; Sun W; Huang J; He L; Dong W; Zhang D; Zhang T; Shao L; Lv C; Zhang P; Zhang H
    Endocr Pract; 2020 Oct; 26(10):1085-1092. PubMed ID: 33471710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes.
    Xu S; Huang H; Qian J; Liu Y; Huang Y; Wang X; Liu S; Xu Z; Liu J
    JAMA Netw Open; 2021 Jul; 4(7):e2118526. PubMed ID: 34313737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer.
    Xu S; Huang H; Dong H; Wang X; Xu Z; Liu S; Liu J
    BMC Cancer; 2023 Sep; 23(1):880. PubMed ID: 37723469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
    Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
    Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
    Zhao H; Gong Y
    Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of surgical strategy for pediatric papillary thyroid carcinoma with low-intermediate risk].
    Zhao L; Li H; He YY; Wang K; Wang J; Yan DG; Ni S; Zhu YM; Liu SY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1396-1402. PubMed ID: 36707942
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis.
    Beom Heo D; Piao Y; Hee Lee J; Ju SH; Yi HS; Su Kim M; Won HR; Won Chang J; Seok Koo B; Eun Kang Y
    Oral Oncol; 2022 Nov; 134():106115. PubMed ID: 36108524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
    Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
    JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
    Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
    Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence.
    Song E; Han M; Oh HS; Kim WW; Jeon MJ; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Sung TY; Kim WG
    Thyroid; 2019 Jan; 29(1):64-70. PubMed ID: 30375260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.
    Adam MA; Pura J; Gu L; Dinan MA; Tyler DS; Reed SD; Scheri R; Roman SA; Sosa JA
    Ann Surg; 2014 Oct; 260(4):601-5; discussion 605-7. PubMed ID: 25203876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.
    Ito Y; Kudo T; Kobayashi K; Miya A; Ichihara K; Miyauchi A
    World J Surg; 2012 Jun; 36(6):1274-8. PubMed ID: 22270990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
    Papachristos A; Do K; Tsang VH; Sywak M; Gill AJ; Sidhu S; Clifton-Bligh RJ; Glover A; Gild ML
    Thyroid; 2022 Sep; 32(9):1086-1093. PubMed ID: 35703333
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    Endocr Relat Cancer; 2016 May; 23(5):367-76. PubMed ID: 26917553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
    Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
    JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
    Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
    Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.